Viewing Study NCT01485861


Ignite Creation Date: 2025-12-24 @ 11:49 AM
Ignite Modification Date: 2026-01-17 @ 1:12 AM
Study NCT ID: NCT01485861
Status: COMPLETED
Last Update Posted: 2023-09-14
First Post: 2011-12-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
Sponsor: Genentech, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GO27983
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators